RBC Capital Reiterates Underperform on D.R. Horton, Maintains $125 Price Target
DR Horton Price Target Maintained With a $210.00/Share by JMP Securities
BofA Securities Maintains D.R. Horton(DHI.US) With Buy Rating
Evercore Maintains D.R. Horton(DHI.US) With Buy Rating, Cuts Target Price to $204
RBC Capital Maintains D.R. Horton(DHI.US) With Sell Rating, Maintains Target Price $125
Citigroup Adjusts Price Target on D.R. Horton to $151 From $152
A Quick Look at Today's Ratings for D.R. Horton(DHI.US), With a Forecast Between $125 to $210
DR Horton Is Maintained at Equal-Weight by Barclays
D.R. Horton Analyst Ratings
Wedbush Adjusts Price Target on D.R. Horton to $174 From $180, Maintains Neutral Rating
JMP Securities Reaffirms Their Buy Rating on DR Horton (DHI)
Wedbush Cuts Price Target on D.R. Horton to $174 From $180, Keeps Neutral Rating
Wedbush Initiates D.R. Horton(DHI.US) With Hold Rating, Announces Target Price $180
Wedbush Sticks to Their Hold Rating for DR Horton (DHI)
Oppenheimer Maintains D.R. Horton(DHI.US) With Hold Rating
Wells Fargo Maintains D.R. Horton(DHI.US) With Buy Rating, Maintains Target Price $175
DR Horton Is Maintained at Equal-Weight by Barclays
D.R. Horton Analyst Ratings
Barclays Maintains D.R. Horton(DHI.US) With Hold Rating, Cuts Target Price to $150
Goldman Sachs Maintains D.R. Horton(DHI.US) With Buy Rating, Cuts Target Price to $171